AiCure

AiCure provides an AI-driven digital health platform that uses computer vision, audio analysis, and predictive analytics to monitor medication adherence, capture digital biomarkers remotely via smartphones, and support patient engagement in clinical trials. Its solutions have demonstrated high rates of medication adherence in published studies—such as a Takeda Phase 2 study reporting over 96% post-discharge adherence—and are used globally by pharmaceutical sponsors to improve data quality and reduce trial dropouts. The company’s technologies are validated against drug levels in blood samples across diverse populations including elderly stroke patients and those with schizophrenia or HIV risk factors.